Please join us for the next
“Biosimilar Uptake In The US: Patient And Prescriber Factors”
Dongzhe Hong is a postdoctoral fellow in the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital and Harvard Medical School. He earned his BS in Pharmaceutical Sciences and MS in Clinical Pharmacy from Peking University. He further obtained an MSPH in Health Policy and Health Services Research from Emory University and a PhD in the same field from Tulane University. His current research focuses on the affordability, effectiveness, and accessibility of novel high-cost drugs, patient-centered clinical decision-making, and prescription drug policy.
Date: Thursday, December 12, 2024
Time: 1:00pm – 2:00pm
Location
Center for the Evaluation of Value and Risk in Health
35 Kneeland St., 7th Floor
Boston, MA 02111
Zoom
Link: https://wellforce.zoom.us/j/92400019396?pwd=0dW2a98q5anPMaCvtCfabtQSnph4rN.1&from=addon
Passcode: 028919
To be added to the e-mail announcement, please email Sarah Mullin at sarah.mullin@tuftsmedicine.org
